Unique ID issued by UMIN | UMIN000003973 |
---|---|
Receipt number | R000004790 |
Scientific Title | Validity of Urine trypsinogen-2 in Diagnosis of Acute Pancreatitis in The Critical Patients with Hyperamylasemia |
Date of disclosure of the study information | 2010/08/01 |
Last modified on | 2011/01/29 09:28:35 |
Validity of Urine trypsinogen-2 in Diagnosis of Acute Pancreatitis in The Critical Patients with Hyperamylasemia
Brief Title: Urine trypsinogen-2 in Diagnosis of Acute Pancreatitis in Hyperamylasemia
Validity of Urine trypsinogen-2 in Diagnosis of Acute Pancreatitis in The Critical Patients with Hyperamylasemia
Brief Title: Urine trypsinogen-2 in Diagnosis of Acute Pancreatitis in Hyperamylasemia
Japan |
the critical patients with hyperamylasemia
Hepato-biliary-pancreatic medicine | Hepato-biliary-pancreatic surgery | Emergency medicine |
Intensive care medicine |
Others
NO
The purpose of this prospective study is to clarify the usefulness of urinary trypsinogen-2 for early diagnosis of acute pancreatitis in the critical patients with hyperamylasemia.
Efficacy
Confirmatory
Explanatory
Phase IV
Evaluate the efficacy of urinary trypsinogen-2 test strip in the diagnosis, severity and prognosis of acute pancreatitis in the critical patients with hyperamylasemia.
((1) Evaluate the correlation of urinary trypsinogen-2 test strip and urinary trypsinogen-2 quantity test.
(2) Compare the efficacy of urinary trypsinogen-2 test strip in the diagnosis of acute pancreatitis with lipase in the critical patients with hyperamylasemia.
(3) Evaluate the correlation of urinary trypsinogen-2 test strip and severity and prognosis of acute pancreatitis in the critical patients with hyperamylasemia.
(4) Evaluate the correlation of urinary trypsinogen-2 test strip and urinary trypsinogen-2 quantity test in the cause of acute pancreatitis in the critical patients with hyperamylasemia.
Observational
15 | years-old | <= |
Not applicable |
Male and Female
the critical patients with hyperamylasemia
Participation in other study that is incompatible with this one.
100
1st name | |
Middle name | |
Last name | Toshihiko Mayumi, M.D. & Ph.D. |
Nagoya University Graduate School of Medicine
Department of Emergency and Critical Care Medicine
65 Tsurumai, Showa,Nagoya, Aichi, 466-8560, Japan
+81-52-744-2659
1st name | |
Middle name | |
Last name | Toshihiko Mayumi, M.D. & Ph.D. |
Nagoya University Graduate School of Medicine
Department of Emergency and Critical Care Medicine
65 Tsurumai, Showa, Nagoya, Aichi, 466-8560, Japan
+81-52-744-2659
mtoshi@med.nagoya-u.ac.jp
Department of Emergency and Critical Care Medicine
Nagoya University Graduate School of Medicine
The Research Committee of Intractable Pancreatic Diseases (Principal investigator: Tooru Shimosegawa) provided by the Ministry of Health, Labour, and Welfare of Japan
Japan
NO
名古屋大学大学医学部附属病院 救急部、集中治療部(愛知県)、名古屋第二赤十字病院(愛知県)
2010 | Year | 08 | Month | 01 | Day |
Partially published
Completed
2009 | Year | 01 | Month | 01 | Day |
2009 | Year | 04 | Month | 01 | Day |
2010 | Year | 10 | Month | 01 | Day |
2010 | Year | 10 | Month | 01 | Day |
2010 | Year | 11 | Month | 01 | Day |
2010 | Year | 11 | Month | 01 | Day |
We are adding the patients about presence or absence of pancreatitis onset, the subsequent course.
2010 | Year | 07 | Month | 31 | Day |
2011 | Year | 01 | Month | 29 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000004790
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |